Maya Hacini

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Richard Delarue, Hervé Tilly, Nicolas Mounier et al. · The Lancet Oncology · 2013 · 303 citations

Medicine, Oncology, Pharmacotherapy +4

The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma

Clémentine Sarkozy, Sarah Huet, Victoria Carlton et al. · Oncotarget · 2017 · 98 citations · Full text

Medicine, Hematology, Oncology +17

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs

Philippe Rodon, Cyrille Hulin, Laurent Daley et al. · Thrombosis and Haemostasis · 2013 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +17

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma

Adrien Chauchet, Anne‐Sophie Michallet, Françoise Berger et al. · Journal of Hematology & Oncology · 2012 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results

Isabelle Thuret, Maya Hacini, Brigitte Pégourié‐Bandelier et al. · Hematology · 2009 · 18 citations

Medicine, Hematology, Pharmacotherapy +17